End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17,760 KRW | +0.06% | -5.98% | -24.90% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 81,029 | 100.0 % | 83,240 | 100.0 % | +2.73% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
95.9
%
| 77,605 | 95.8 % | 79,794 | 95.9 % | +2.82% |
Overseas
4.1
%
| 3,424 | 4.2 % | 3,446 | 4.1 % | +0.65% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Eun-Hee Park
CEO | Chief Executive Officer | 57 | - |
Yong-Ki Park
DFI | Director of Finance/CFO | 63 | - |
Seung-Hee Han
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Chan-Bok Lee
SAM | Sales & Marketing | 55 | - |
Byung-Jin Lee
SAM | Sales & Marketing | 65 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jin-Hyoung Kim
BRD | Director/Board Member | 47 | 22-03-29 |
Jae-Don Park
BRD | Director/Board Member | 88 | - |
Eun-Hee Park
CEO | Chief Executive Officer | 57 | - |
Yong-Ki Park
DFI | Director of Finance/CFO | 63 | - |
Won-Myung Park
BRD | Director/Board Member | 65 | - |
Beon-Gil Choi
BRD | Director/Board Member | 49 | 22-03-29 |
Chun-Soo Im
BRD | Director/Board Member | 59 | 22-03-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,906,701 | 3,860,982 ( 35.40 %) | 0 | 35.40 % |
Company contact information
KOREA PHARMA Co., Ltd.
87 Jeyakgongdan 3-gil Hyangnam-eup
18622, Hwaseong-si
+
http://www.koreapharma.co.krSector
Sales per region
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.90% | 140M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- A032300 Stock
- Company KOREA PHARMA Co., Ltd.